Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure.

Journal of acquired immune deficiency syndromes (1999) - 1 Jan 2006

Gange Stephen J, Schneider Michael F, Grant Robert M, Liegler Teri, French Audrey, Young Mary, Anastos Kathryn, Wilson Tracey E, Ponath Claudia, Greenblatt Ruth

Abstract excerpt

OBJECTIVES: To describe the prevalence of specific protease inhibitor (PI) and nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance mutations and the relationship between the presence of these mutations and immunologic outcomes following PI/NNRTI initiation among a cohort of HIV-1-infected women. METHODS: Viral genotypic resistance testing was done for 366 women enrolled in the Women's Interagency HIV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD4 Lymphocyte Count
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to RNA-Directed DNA Polymerase

Share to RNA, Viral

Share to Treatment Failure

Share to Viral Load

Source

Identifiers

PMID: 16340476
DOI: 10.1097/01.qai.0000174652.40782.4e

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure.PMID 16340476Read ↗

Genotypic testing for human immunodeficiency virus type 1 drug resistance.Semantic proximity Read ↗

Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological FailureSemantic proximity Read ↗

Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy.Semantic proximity Read ↗

Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview.Semantic proximity Read ↗

Long-term immunologic and virologic responses in patients with highly resistant HIV infection who are treated with an incompletely suppressive antiretroviral regimen.Semantic proximity Read ↗

HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization.Semantic proximity Read ↗

Resistance of human immunodeficiency virus type 1 to reverse transcriptase and protease inhibitors: genotypic and phenotypic testing.Semantic proximity Read ↗

Adherence and preexisting major protease inhibitor resistance mutations are associated with virologic failure of a dual-class antiretroviral regimen with inhibitors of HIV-1 viral protease and integrase.Semantic proximity Read ↗

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.Semantic proximity Read ↗

96-Week resistance analyses of rilpivirine in treatment-naive, HIV-1-infected adults from the ECHO and THRIVE Phase III trials.Semantic proximity Read ↗

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.Semantic proximity Read ↗

Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.